Hospice organizations operate under a fixed, per-diem Medicare benefit, so the hospice itself bears the cost of medications rather than passing that cost to an insurer (CMS, Medicare Hospice Payment). That structure makes every unnecessary delivery fee, every high-cost medication ordered without a check, and every missed formulary update a direct hit to the organization's margin, not a line item someone else absorbs.
Cutting costs by simply denying medications or delaying fulfillment isn't a real strategy. It shows up almost immediately as patient discomfort and nurse frustration. The strategies below reduce spend by improving the decisions made earlier in the process, not by rationing care.
Use this as a starting checklist for a cost review.
None of these seven strategies work well in isolation. A pre-approved alternative list only helps if clinicians actually see it at the moment they're prescribing, and a transparent pricing model only matters if someone is reviewing the data it produces. The strategies compound when they're built into the same workflow instead of managed as seven separate initiatives, which is why the technology behind them matters as much as the strategies themselves.
Even well-intentioned cost-reduction efforts can stall out, and it's usually not because the strategy was wrong. It's because the process around it didn't hold up.
BetterRX builds most of these strategies directly into Intelligent Medication Management so they happen automatically rather than depending on someone remembering to check. BetterRX Guardrails™ surface high-cost medications and lower-cost alternatives at the exact moment of ordering, and the Delivery Consolidation Guardrail automatically groups eligible orders headed to the same pharmacy while keeping STAT and after-hours orders excluded by default, and clinicians can always override to send meds immediately.
In Beta testing, 100% of users agreed that Interchange Manager™, BetterRX's tool for pre-approved therapeutic alternatives, was easy to use and useful, and cost savings was the most frequently cited reason it mattered (Source: Interchange Manager™ Beta Survey). Per BetterRX's Voice of the Customer survey across six consecutive years, 93.8% of clients report satisfaction with the cost-savings tools and resources BetterRX provides to help them hit their PPD goals.
Ease matters for cost control. A cost-saving decision built into the workflow itself gets used, while one more report to review after the spending has already happened often doesn't.
A real cost-reduction strategy protects the medications patients actually need and simply removes the waste around them: avoidable delivery fees, high-cost drugs with an equally effective lower-cost option, and formulary gaps that force expensive workarounds. Hospice leaders evaluating any cost-reduction approach should ask whether it's reducing waste or reducing access. Only the first one is proactive cost control.
In practice, that distinction shows up in small moments: a nurse who can select a pre-approved alternative without waiting on an approval call, or a finance leader who can see a cost trend the same week it starts instead of the month after. Those moments are where proactive cost control either holds or breaks down, and they're worth designing the workflow around directly.
Why this matters most is Predictable PPD. When cost-aware decisions happen automatically at the point of ordering instead of showing up as a surprise in a monthly report, per-patient-day spend becomes something a hospice can actually forecast rather than something it discovers after the fact.